Mesotherapy & Lipotherapy News Search

Welcome to The Consulting Room Cosmetic Treatment and Surgery News Area

Aqualyx injections 'break down fat cells that pass through urine', claim makers

A new injection has been invented, which its makers claim dissolves fat cells and allows us to pass them out of our bodies when we urinate. The new treatment, dubbed Aqualyx, claims to be an effective alternative to liposuction - and Sharon Donaldson, 39, from Liverpool, was one of the first women to try it. Sharon paid £1000 to have fat zapping treatment on her face and midriff, before getting married to Peter, 32, last year.

New injectable on the horizon targets the `double chin`

The advent of Facebook, the IPhone and Skype has placed the double chin front and center. Certainly, the image of yourself you see, using any of these devices, face pointed downward, is likely to be with folds of chin fat. Kythera Biopharmaceuticals is capitalizing on this trend. They went public in October 2012 on the strength of ATX-101, an injectable drug aimed at reducing the double chin.

Kythera IPO is Seeking $86.2M for ATX-101 U.S. Phase III

Aesthetic specialist Kythera Biopharmaceuticals Inc. filed an S-1 with the SEC seeking to raise $86.2 million in an initial public offering, with "substantially all" of the net proceeds used to fund U.S. Phase III trials of lead compound ATX-101.

Is this lipo for the face?

Goodbye fillers and mountainous cheeks: the new flab jab attacks jowls and double chins instead. Whenever a cosmetic doctor approaches a patient with a syringe, we can pretty much guess that the outcome is going to be a bigger face. Filler injections designed to plump out ageing faces are now almost mandatory for celebrities of a certain age and we have become used to spotting the mountainous cheeks of certain stars hoping to keep the years at bay.